• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Aprea Therapeutics, Inc. - Common Stock (NQ:APRE)

    0.8180 +0.0181 (+2.26%)
    Streaming Delayed Price Updated: 3:55 PM EDT, May 1, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 46,036
    Open 0.7901
    Bid (Size) 0.8179 (200)
    Ask (Size) 0.8180 (7,300)
    Prev. Close 0.7999
    Today's Range 0.7901 - 0.8180
    52wk Range 0.5480 - 2.220
    Shares Outstanding 5,979,292
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting
    From Aprea Therapeutics
    Via GlobeNewswire
    News headline image
    Aprea Therapeutics Announces Closing of Oversubscribed $30 Million Private Placement
    Funding will support ongoing development of APR-1051, including expansion into selected patient populations where WEE1 mechanism is well suited 
    From Aprea Therapeutics
    Via GlobeNewswire

    Performance

    YTD
    -4.1%
    -4.1%
    1 Month
    +7.2%
    +7.2%
    3 Month
    +38.6%
    +38.6%
    6 Month
    -43.6%
    -43.6%
    1 Year
    -53.0%
    -53.0%

    More News

    Read More
    News headline image
    Aprea Therapeutics Announces Oversubscribed $30 Million Private Placement
    From Aprea Therapeutics
    Via GlobeNewswire
    News headline image
    Aprea Therapeutics Highlights Positive Emerging Clinical Activity for WEE1 Inhibitor, APR-1051, with a Confirmed Partial Response in the Ongoing Phase 1 ACESOT-1051 Trial
    From Aprea Therapeutics
    Via GlobeNewswire
    Gapping stocks in Monday's session ↗
    Via Chartmill
    News headline image
    Aprea Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
    From Aprea Therapeutics
    Via GlobeNewswire
    News headline image
    Aprea Therapeutics Stock Rises After Company Reports Second Unconfirmed Case Of Tumor Reduction In Trial ↗
    Via Stocktwits
    The market is filled with gapping stocks in Wednesday's session. ↗
    Via Chartmill
    News headline image
    Aprea Therapeutics Announces Additional Positive Clinical Activity for WEE1 Inhibitor, APR-1051, Including Second Partial Response in Ongoing ACESOT-1051 Trial
    From Aprea Therapeutics
    Via GlobeNewswire
    News headline image
    Aprea Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
    From Aprea Therapeutics
    Via GlobeNewswire
    News headline image
    Aprea Therapeutics Strengthens Global Patent Portfolio in DNA Damage Response (DDR) Cancer Therapeutics, Paving Way for Pipeline Growth
    From Aprea Therapeutics
    Via GlobeNewswire
    News headline image
    Aprea Therapeutics Appoints Industry Veteran Eugene Kennedy, MD, as Chief Medical Advisor
    From Aprea Therapeutics
    Via GlobeNewswire
    Let's take a look at the stocks that are in motion in today's session. ↗
    Via Chartmill
    Check out the stocks that are attracting the most attention and driving market activity. ↗
    Via Chartmill
    In today's session, these stocks are experiencing unusual volume. ↗
    Via Chartmill
    Top movers analysis in the middle of the day on 2026-01-30: top gainers and losers in today's session. ↗
    Via Chartmill
    What's going on in today's after hours session ↗
    Via Chartmill
    News headline image
    Aprea Therapeutics Announces Early Clinical Proof-Of-Concept in the Ongoing ACESOT-1051 Dose-Escalation Trial Evaluating WEE1 Inhibitor APR-1051, Including Partial Response Observed on First Scan
    From Aprea Therapeutics
    Via GlobeNewswire
    News headline image
    Aprea Therapeutics Announces $5.6 Million Private Placement Priced At-The-Market Under Nasdaq Rules
    From Aprea Therapeutics
    Via GlobeNewswire
    News headline image
    Aprea Therapeutics CEO Issues Letter to Shareholders Highlighting Pipeline Progress in 2025 and Outlook for 2026
    From Aprea Therapeutics
    Via GlobeNewswire
    News headline image
    Game-Changing News: BEAT, APRE, TOON, MNTS, PRSO, PNPNF, SIGL – Stocks Under $1 Look Now
    Via AB Newswire
    News headline image
    Aprea Therapeutics Announces $3.1 Million Private Placement Priced At-The-Market Under Nasdaq Rules
    From Aprea Therapeutics
    Via GlobeNewswire
    News headline image
    Datavault AI (NASDAQ: DVLT) a Promising FY26 Forward Multiple, Reports +148% Q3, Expands Tokenization Globally – More Similar Stocks Inside.
    Via AB Newswire
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Aprea Therapeutics (Nasdaq: APRE) Advances Cancer Pipeline as Maxim Group Sets $10 Price Target
    Via AB Newswire
    News headline image
    Signal Advance (OTC: SIGL) CEO on The Street Podcast – Unveiling Physics-Based Encryption Built for the AI and Quantum Computing Era
    Via AB Newswire
    Topics Artificial Intelligence Intellectual Property

    Frequently Asked Questions

    Is Aprea Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Aprea Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Aprea Therapeutics, Inc. - Common Stock trade on?
    Aprea Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Aprea Therapeutics, Inc. - Common Stock?
    The ticker symbol for Aprea Therapeutics, Inc. - Common Stock is APRE on the Nasdaq Stock Market
    What is the current price of Aprea Therapeutics, Inc. - Common Stock?
    The current price of Aprea Therapeutics, Inc. - Common Stock is 0.8180
    When was Aprea Therapeutics, Inc. - Common Stock last traded?
    The last trade of Aprea Therapeutics, Inc. - Common Stock was at 05/01/26 03:55 PM ET
    What is the market capitalization of Aprea Therapeutics, Inc. - Common Stock?
    The market capitalization of Aprea Therapeutics, Inc. - Common Stock is 4.89M
    How many shares of Aprea Therapeutics, Inc. - Common Stock are outstanding?
    Aprea Therapeutics, Inc. - Common Stock has 5M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.